Suitable test concentration of cobalt and concomitant reactivity to nickel and chromium: A multicentre study from the Swedish Contact Dermatitis Research Group.


Journal

Contact dermatitis
ISSN: 1600-0536
Titre abrégé: Contact Dermatitis
Pays: England
ID NLM: 7604950

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 26 06 2020
revised: 17 09 2020
accepted: 27 09 2020
pubmed: 1 10 2020
medline: 27 10 2021
entrez: 30 9 2020
Statut: ppublish

Résumé

In Sweden, cobalt chloride 0.5% has been included in the baseline series since the mid-1980s. A recent study from Stockholm showed that cobalt chloride 1% petrolatum (pet.) was more suitable than 0.5%. Cobalt chloride at 1.0% has been patch tested for decades in many European countries and around the world. To study the suitability of patch testing to cobalt 1.0% vs 0.5% and to analyze the co-occurrence of allergy to cobalt, chromium, and nickel. Contact allergy to cobalt was shown in 90 patients (6.6%). Eighty (5.9%) patients tested positive to cobalt 1.0%. Thirty-seven of the 90 patients (41.1%) with cobalt allergy were missed by cobalt 0.5% and 10 (0.7%) were missed by cobalt 1.0% (P < .001). No case of patch test sensitization was reported. Allergy to chromium was seen in 2.6% and allergy to nickel in 13.3%. Solitary allergy to cobalt without nickel allergy was shown in 61.1% of cobalt-positive individuals. Female patients had larger proportions of positive reactions to cobalt (P = .036) and nickel (P < .001) than males. The results speak in favor of replacing cobalt chloride 0.5% with cobalt chloride 1.0% pet. in the Swedish baseline series, which will be done 2021.

Sections du résumé

BACKGROUND BACKGROUND
In Sweden, cobalt chloride 0.5% has been included in the baseline series since the mid-1980s. A recent study from Stockholm showed that cobalt chloride 1% petrolatum (pet.) was more suitable than 0.5%. Cobalt chloride at 1.0% has been patch tested for decades in many European countries and around the world.
OBJECTIVES OBJECTIVE
To study the suitability of patch testing to cobalt 1.0% vs 0.5% and to analyze the co-occurrence of allergy to cobalt, chromium, and nickel.
RESULTS RESULTS
Contact allergy to cobalt was shown in 90 patients (6.6%). Eighty (5.9%) patients tested positive to cobalt 1.0%. Thirty-seven of the 90 patients (41.1%) with cobalt allergy were missed by cobalt 0.5% and 10 (0.7%) were missed by cobalt 1.0% (P < .001). No case of patch test sensitization was reported. Allergy to chromium was seen in 2.6% and allergy to nickel in 13.3%. Solitary allergy to cobalt without nickel allergy was shown in 61.1% of cobalt-positive individuals. Female patients had larger proportions of positive reactions to cobalt (P = .036) and nickel (P < .001) than males.
CONCLUSION CONCLUSIONS
The results speak in favor of replacing cobalt chloride 0.5% with cobalt chloride 1.0% pet. in the Swedish baseline series, which will be done 2021.

Identifiants

pubmed: 32996589
doi: 10.1111/cod.13710
doi:

Substances chimiques

Allergens 0
Cobalt 3G0H8C9362
nickel sulfate 4FLT4T3WUN
Nickel 7OV03QG267
cobaltous chloride EVS87XF13W
Potassium Dichromate T4423S18FM

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

153-158

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Lidén C, Andersson N, Julander A, Matura M. Cobalt allergy: suitable test concentration, and concomitant reactivity to nickel and chromium. Contact Dermatitis. 2016;74(6):360-367.
Alinaghi F, Zachariae C, Thyssen JP, Johansen JD. Causative exposures and temporal development of cobalt allergy in Denmark between 2002 and 2017. Contact Dermatitis. 2019;81(4):242-248.
Uter W, Gefeller O, Geier J, Schnuch A. Contact sensitization to cobalt-multifactorial analysis of risk factors based on long-term data of the information network of departments of dermatology. Contact Dermatitis. 2014;71(6):326-337.
Warshaw EM, Aschenbeck KA, DeKoven JG, et al. Piercing and metal sensitivity: extended analysis of the North American Contact Derma- titis Group data, 2007-2014. Dermatitis. 2017;28(6):333-341.
Fischer T, Rystedt I. False-positive, follicular and irritant patch test reactions to metal salts. Contact Dermatitis. 1985;12(2):93-98.
Bruze M, Isaksson M, Gruvberger B, Frick-Engfeldt M. Recommendation of appropriate amounts of petrolatum preparation to be applied at patch testing. Contact Dermatitis. 2007;56(5):281-285.
Fregert S. Manual of Contact Dermatitis. 2nd ed. Copenhagen, Denmark: Munksgaard; 1981.
Johansen JD, Aalto-Korte K, Agner T, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. Contact Dermatitis. 2015;73(4):195-221.
Micallef L, Rodgers P. eulerAPE: drawing area-proportional 3-Venn diagrams using ellipses. PLos One. 2014;9(7):e101717
Lagrelius M, Wahlgren CF, Matura M, Kull I, Lidén C. High prevalence of contact allergy in adolescence: results from the population-based BAMSE birth cohort. Contact Dermatitis. 2016;74(1):44-51.
Hegewald J, Uter W, Pfahlberg A, Geier J, Schnuch A, IVDK. A multifactorial analysis of concurrent patch-test reactions to nickel, cobalt, and chromate. Allergy. 2005;60(3):372-378.
Svedman C, Isaksson M, Björk J, Mowitz M, Bruze M. Calibration' of our patch test reading technique is necessary. Contact Dermatitis. 2012;66(4):180-187.
Bruze M. Thoughts on how to improve the quality of multicentre patch test studies. Contact Dermatitis. 2016;74(3):168-174.
Thyssen JP, Ahlström MG, Bruze M, Rustemeyer T, Lidén C. Contact allergy to metals. In: Johansen JD, Mahler V, Lepoittevin J-P, Frosch P, eds. Contact Dermatitis. 6th ed. Berlin, Germany: Springer Cham; 2020.
Hamann C, Hamann D, Hamann KK, Thyssen JP. Cobalt release from inexpensive earrings from Thailand and China. Contact Dermatitis. 2011;64(4):238-240.
Thyssen JP, Jellesen MS, Menné T, et al. Cobalt release from inexpensive jewellery: has the use of cobalt replaced nickel following regulatory intervention? Contact Dermatitis. 2010;63(2):70-76.
Boonchai W, Maneeprasopchoke P, Suiwongsa B, Kasemsarn P. Assessment of nickel and cobalt release from jewelry from a non- nickel directive country. Dermatitis. 2015;26(1):44-48.
Uter W, Schmid M, Schmidt O, Bock C, Wolter J. Cobalt release from earrings and piercing jewellery-analytical results of a German survey. Contact Dermatitis. 2014;70(6):369-375.

Auteurs

Marléne Isaksson (M)

Lund University, Department of Occupational and Environmental Dermatology, Skåne University Hospital, Malmö, Sweden.

Lina Hagvall (L)

Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Dermatology and Venereology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.

Bo Glas (B)

Department of Public Health and Clinical Medicine, Dermatology and Venereology, Umeå University, Umeå, Sweden.

Maria Lagrelius (M)

Institute of Environmental Medicine, Karolinska Institutet and Centre for Occupational and Environmental Medicine, Stockholm, Sweden.

Carola Lidén (C)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Mihaly Matura (M)

Institute of Environmental Medicine, Karolinska Institutet and Centre for Occupational and Environmental Medicine, Stockholm, Sweden.
Department of Dermatology, Skaraborg's Hospital, Skövde, Sweden.

Gunnar Nyman (G)

Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Dermatology and Venereology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.

Berndt Stenberg (B)

Department of Public Health and Clinical Medicine, Dermatology and Venereology, Umeå University, Umeå, Sweden.

Cecilia Svedman (C)

Lund University, Department of Occupational and Environmental Dermatology, Skåne University Hospital, Malmö, Sweden.

Magnus Bruze (M)

Lund University, Department of Occupational and Environmental Dermatology, Skåne University Hospital, Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH